ACHL.NASDAQ | Achilles Therapeutics PLC ADR | USA | Healthcare | Biotechnology | 2024-09-30 | 0.933 | 0.017 | 366.9k | $1m | $421.9k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
ACRV.NASDAQ | Acrivon Therapeutics, Inc. Common Stock | USA | Healthcare | Biotechnology | 2024-09-30 | 1.82 | 0.188 | 566.6k | $2.9m | $3.5m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
AFMD.NASDAQ | Affimed NV | USA | Healthcare | Biotechnology | 2024-09-30 | 0.889 | 0.033 | 1.3m | $1.4m | $1.6m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
ALIM.NASDAQ | ALIM.NASDAQ | - | - | - | - | 0.858 | 0.126 | 466.6k | - | - | | |
ALLK.NASDAQ | Allakos Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.679 | 0.047 | 1.5m | $1.2m | $1.8m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
ALXO.NASDAQ | Alx Oncology Holdings | USA | Healthcare | Biotechnology | 2024-09-30 | 2.844 | 0.13 | 1.5m | $3.8m | $2.5m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
AMAM.NASDAQ | AMAM.NASDAQ | - | - | - | - | 1.344 | 0.495 | 833.4k | - | - | | |
AMAM.NYSE | AMAM.NYSE | - | - | - | - | 2.173 | 0.13 | 1.2m | - | - | | |
APLT.NASDAQ | Applied Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.276 | 0.13 | 321.6k | $16.4k | $285.2k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
APTX.NASDAQ | APTX.NASDAQ | - | - | - | - | 0.792 | 0.013 | 536.2k | - | - | | |
ARQT.NASDAQ | Arcutis Biotherapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.295 | 0.557 | 791k | $996.7k | $11.8m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
ATNX.NASDAQ | ATNX.NASDAQ | - | - | - | - | 0.148 | 0.003 | 233.2k | - | - | | |
BCAB.NASDAQ | Bioatla Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.257 | 0.075 | 599.3k | $284.7k | $383.6k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
BHVN.NYSE | Biohaven Pharmaceutical Holding Co Ltd | USA | Healthcare | Biotechnology | 2024-09-30 | 0.884 | 2.118 | 893.3k | $2.7m | $31.9m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
BMEA.NASDAQ | Biomea Fusion Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.059 | 0.545 | 375k | $786k | $1.5m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
BYSI.NASDAQ | BeyondSpring Inc | USA | Healthcare | Biotechnology | 2024-06-30 | 0.737 | 0.014 | 287k | -$167k | $476.7k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
CBAY.NASDAQ | CBAY.NASDAQ | - | - | - | - | 0.523 | 0.71 | 600k | - | - | | |
CCXI.NASDAQ | CCXI.NASDAQ | - | - | - | - | 1.029 | 1.829 | 739.8k | - | - | | |
CLDX.NASDAQ | Celldex Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.777 | 0.603 | 425k | $5m | $10.9m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
CLLS.NASDAQ | Cellectis SA | USA | Healthcare | Biotechnology | 2024-09-30 | 0.769 | 0.042 | 350k | $452.5k | $528.5k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
CNTB.NASDAQ | Connect Biopharma Holdings Ltd | USA | Healthcare | Biotechnology | 2024-06-30 | 1.592 | 0.037 | 876.6k | $1.6m | $873.1k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
COGT.NASDAQ | Cogent Biosciences Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.101 | 0.477 | 947.7k | $2.7m | $7.4m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
CRBP.NASDAQ | Corbus Pharmaceuticals Holding | USA | Healthcare | Biotechnology | 2024-09-30 | 2.627 | 0.313 | 320k | $3.9m | $4.2m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
CTIC.NASDAQ | CTIC.NASDAQ | - | - | - | - | 0.44 | 0.114 | 579.9k | - | - | | |
EPZM.NASDAQ | EPZM.NASDAQ | - | - | - | - | 2.788 | 0.296 | 4.6m | - | - | | |
ESPR.NASDAQ | Esperion Therapeutics Inc | USA | Healthcare | Drug Manufacturers - Specialty & Generic | 2024-09-30 | 0.725 | 0.171 | 534k | -$1m | $1.2m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
EYPT.NASDAQ | Eyepoint Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.733 | 0.19 | 500k | $1.6m | $3.7m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
GLTO.NASDAQ | Galecto Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.373 | 0.007 | 94.7k | $1.5m | $460.4k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
GLUE.NASDAQ | Monte Rosa Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 2.29 | 0.354 | 1.4m | $3.5m | $9.9m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
HOWL.NASDAQ | Werewolf Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.89 | 0.04 | 396.8k | $795.9k | $630.9k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
HRMY.NASDAQ | Harmony Biosciences Holdings | USA | Healthcare | Biotechnology | 2024-09-30 | 3.766 | 4.076 | 2.1m | $22m | $74.5m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 7/10 | 70.0% | | Total | 7/10 | 70.0% | |
---|
| |
IMGN.NASDAQ | IMGN.NASDAQ | - | - | - | - | 0.451 | 1.869 | 1.2m | - | - | | |
IOBT.NASDAQ | IO Biotech Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 5.987 | 0.197 | 3.9m | $4.3m | $3.7m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
JSPR.NASDAQ | Jasper Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.667 | 0.223 | 250k | $1.3m | $5.6m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
KALV.NASDAQ | Kalvista Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-07-31 | 0.723 | 0.075 | 177.8k | $624.5k | $1.5m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
KDNY.NASDAQ | KDNY.NASDAQ | - | - | - | - | 0.627 | 0.798 | 450k | - | - | | |
KURA.NASDAQ | Kura Oncology Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.643 | 0.463 | 500k | $2.4m | $4.4m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
LBPH.NASDAQ | Longboard Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 3.467 | 0.407 | 1.3m | $9.5m | $80.8m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
MRSN.NASDAQ | Mersana Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.503 | 0.092 | 605.5k | $4.8k | $859.9k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
MRUS.NASDAQ | Merus BV | USA | Healthcare | Biotechnology | 2024-09-30 | 1.249 | 2.027 | 855.1k | $8.7m | $36.8m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
OMER.NASDAQ | Omeros Corporation | USA | Healthcare | Biotechnology | 2024-09-30 | 1.408 | 0.095 | 884.5k | -$2.3m | $9.2m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
PCRX.NASDAQ | Pacira BioSciences, Inc. | USA | Healthcare | Drug Manufacturers - Specialty & Generic | 2024-09-30 | 0.978 | 0.322 | 451.3k | $7.3m | $8.7m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
PSTX.NASDAQ | Poseida Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.35 | 0.033 | 300k | $266.4k | $2.8m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 8/10 | 80.0% | | Total | 8/10 | 80.0% | |
---|
| |
PYXS.NASDAQ | Pyxis Oncology Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.207 | 0.125 | 717.8k | $1.8m | $1.1m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
RCKT.NASDAQ | Rocket Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.742 | 0.593 | 676.3k | $2.3m | $8.1m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
RNAC.NASDAQ | Cartesian Therapeutics Inc. | USA | Healthcare | Biotechnology | 2024-09-30 | 1.623 | 0.315 | 412.3k | $12.7k | $7.6m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
STOK.NASDAQ | Stoke Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.071 | 0.131 | 495.8k | $2m | $5.5m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
TERN.NASDAQ | Terns Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.791 | 0.266 | 671.9k | $2.8m | $3.9m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
THRX.NASDAQ | THRX.NASDAQ | - | - | - | - | 1.147 | 0.215 | 500k | - | - | | |
TIL.NASDAQ | Instil Bio Inc. | USA | Healthcare | Biotechnology | 2024-09-30 | 0.444 | 0.018 | 577k | $15.5m | $12.3m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
TPTX.NASDAQ | TPTX.NASDAQ | - | - | - | - | 1.74 | 2.809 | 871.1k | - | - | | |
TRIL.NASDAQ | TRIL.NASDAQ | - | - | - | - | 1.805 | 1.209 | 1.8m | - | - | | |
TVTX.NASDAQ | Travere Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.724 | 0.995 | 1.5m | -$525k | $26.6m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
VERA.NASDAQ | Vera Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.677 | 0.222 | 300k | $1.3m | $12.7m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
VRDN.NASDAQ | Viridian Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.475 | 0.273 | 250k | $2.2m | $4.7m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
YMAB.NASDAQ | Y mAbs Therapeutics | USA | Healthcare | Biotechnology | 2024-09-30 | 7.363 | 2.057 | 3.2m | $6.8m | $26.3m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
ZGNX.NASDAQ | ZGNX.NASDAQ | - | - | - | - | 2.386 | 0.769 | 1.3m | - | - | | |
ZYME.NASDAQ | Zymeworks Inc. Common Stock | USA | Healthcare | Biotechnology | 2024-09-30 | 2.464 | 1.01 | 1.6m | $8.1m | $24.6m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 2/10 | 20.0% | | Total | 2/10 | 20.0% | |
---|
| |
ZYME.NYSE | ZYME.NYSE | - | - | - | - | 2.336 | 0.635 | 1.4m | - | - | | |